vitamin B12 monoclonal antibodies (Kyto)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevitamin B12 monoclonal antibodies (Kyto)
Drug Alias NameBTma311BTma512T-12 development (Kyto)BTma22BTma84 +[8] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionVitamin B12 modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReceptagen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReceptagen CorpKyto Technology and Life Science Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A